# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001485003-21-000198
Filing Date
2021-10-12
Accepted
2021-10-12 08:00:36
Documents
16
Period of Report
2021-10-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sesn-20211012.htm iXBRL | 8-K | 43545
2 | EX-99.1 | a20211012newhirespr_fina.htm | EX-99.1 | 11547
6 | GRAPHIC | a20211012newhirespr_fina001.jpg | GRAPHIC | 271694
7 | GRAPHIC | a20211012newhirespr_fina002.jpg | GRAPHIC | 306004
8 | GRAPHIC | a20211012newhirespr_fina003.jpg | GRAPHIC | 255166
| Complete submission text file | 0001485003-21-000198.txt |  | 1350421

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20211012.xsd | EX-101.SCH | 1914
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20211012_lab.xml | EX-101.LAB | 24993
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20211012_pre.xml | EX-101.PRE | 13190
9 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20211012_htm.xml | XML | 11816

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211316940
SIC: 2834 Pharmaceutical Preparations